Comparative study of brain aging in healthy individuals and those with multiple sclerosis
Official title: Brain Aging - a Comparative Study in Healthy and Patients With Multiple Sclerosis as Model of a Chronic Neuroinflammatory Disorder (BrainAgeMS)
Run by Insel Gruppe AG, University Hospital Bern · NCT06221631 · Data updated 2026-11-12
This study is testing new MRI techniques to see how brain aging differs between healthy people and those with multiple sclerosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern, Canton of Bern) |
| Status | Recruiting |
| Started | August 27, 2024 |
| Main results expected | March 2028 |
| Study ends | October 2028 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT06221631 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy individuals and patients diagnosed with multiple sclerosis aged 18 to 65 with an EDSS score of 6.0 or lower.
✕Probably not a fit
Patients with other neurological diseases or those who do not meet the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates new quantitative MRI sequences to assess age-specific data for predicting brain aging in both healthy individuals and patients with multiple sclerosis. Participants will undergo blood examinations to determine biological age, clinical evaluations for various parameters, and advanced MRI scans using chemical exchange saturation transfer and T1-relaxometry on a 7 Tesla MRI. The data collected from healthy controls will help establish a normative brain age dataset, which could be utilized for training predictive models for brain aging.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of brain aging in multiple sclerosis and improve predictive models for patient outcomes.
How similar studies have gone: While studies on brain aging and multiple sclerosis exist, this approach utilizing advanced MRI techniques and biological age assessment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Informed Consent signed by the subject * Group 1: Any healthy individual between 18 and 65 years of age * Group 2: Any individuals with any diagnosis of Multiple Sclerosis between 18 and 65 years of age and EDSS ≤6.0. Exclusion Criteria: * Group 1 and 2: Any other neurological disease except primary headaches: insufficient language skills in German or French; pregnancy, lactation, any contraindication for MRI (active implants, passive ferromagnetic implants, passive non-ferromagnetic metallic implants \>4cm in the region covered by the active RF coils, large tattoos inside a region covered by the active radiofrequency (RF) coils, claustrophobia or suspected/known non-compliance), smoking within the last 10 years prior recruitment, any other drug consumption except moderate alcohol intake (less than a standard drink containing 10 grams of alcohol per day) or use of medical cannabis, any previous head trauma (with known/suspected intracranial consequences), Body Mass Index (BMI) \>30, and any other chronic progressive disease. * Specific Criteria for group 1: The calculated biological age (BioAge R Package algorithm) differs by \> -8/+1 years from the chronological age. These patients will not be further invited for a study visit with clinical examination and MRI. * Specific Criteria for group 2: EDSS \> 6.0 as this impacts physical testing; clinical relapse within the last 6 months
Where it's running
-
Inselspital Bern
Bern, Canton of Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Robert Hoepner, PD Dr.med. — Head of the MS outpatient clinic
- Study coordinator: Alejandro X. León Betancourt, Dr.med.
- Email: alejandro.betancourt@insel.ch
- Phone: +41316326093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.